LTPA2019017I1 - Oftalmologinės kompozicijos ir jų panaudojimas - Google Patents

Oftalmologinės kompozicijos ir jų panaudojimas

Info

Publication number
LTPA2019017I1
LTPA2019017I1 LTPA2019017C LTPA2019017I1 LT PA2019017 I1 LTPA2019017 I1 LT PA2019017I1 LT PA2019017 C LTPA2019017 C LT PA2019017C LT PA2019017 I1 LTPA2019017 I1 LT PA2019017I1
Authority
LT
Lithuania
Prior art keywords
applications
ophthalmic compositions
ophthalmic
compositions
Prior art date
Application number
Other languages
English (en)
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Publication of LTPA2019017I1 publication Critical patent/LTPA2019017I1/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
LTPA2019017 2005-03-09 2019-11-07 Oftalmologinės kompozicijos ir jų panaudojimas LTPA2019017I1 (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502357A FR2882930B1 (fr) 2005-03-09 2005-03-09 Nouvelles compositions ophtalmologiques et leur mode d'utilisation
PCT/FR2006/000528 WO2006095095A1 (fr) 2005-03-09 2006-03-09 Compositions ophtalmologiques et leur mode d’utilisation

Publications (1)

Publication Number Publication Date
LTPA2019017I1 true LTPA2019017I1 (lt) 2019-12-10

Family

ID=35058756

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP06726059.6T LT1858481T (lt) 2005-03-09 2006-03-09 Oftalmologinės kompozicijos ir jų panaudojimas
LTPA2019017 LTPA2019017I1 (lt) 2005-03-09 2019-11-07 Oftalmologinės kompozicijos ir jų panaudojimas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP06726059.6T LT1858481T (lt) 2005-03-09 2006-03-09 Oftalmologinės kompozicijos ir jų panaudojimas

Country Status (26)

Country Link
US (2) US20080194649A1 (lt)
EP (1) EP1858481B1 (lt)
JP (1) JP2008532985A (lt)
KR (1) KR20070111501A (lt)
CN (1) CN101151018A (lt)
CA (1) CA2598503C (lt)
CY (2) CY1121865T1 (lt)
DK (1) DK1858481T3 (lt)
ES (1) ES2728071T3 (lt)
FR (1) FR2882930B1 (lt)
HR (1) HRP20191044T1 (lt)
HU (1) HUE043668T2 (lt)
IL (1) IL185197A0 (lt)
LT (2) LT1858481T (lt)
LU (1) LUC00136I2 (lt)
MA (1) MA29269B1 (lt)
MX (1) MX2007010295A (lt)
NL (1) NL301017I2 (lt)
NO (2) NO339793B1 (lt)
PL (1) PL1858481T3 (lt)
PT (1) PT1858481T (lt)
RU (1) RU2392925C2 (lt)
SI (1) SI1858481T1 (lt)
TN (1) TNSN07343A1 (lt)
TR (1) TR201908487T4 (lt)
WO (1) WO2006095095A1 (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8602959B1 (en) * 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
EP2675455A4 (en) * 2011-02-18 2014-07-16 M S Appasamy Associates OPHTHALMIC COMPOSITION FOR DILATING PUPILS
ITPA20110004A1 (it) * 2011-02-23 2012-08-24 Francesco Paolo Montalto Iniezione intracamerulare per anestesia e dilatazione pupillare (midriasi).
CN103159672A (zh) * 2012-07-16 2013-06-19 湖南尔文生物科技有限公司 一种托品酰胺的制备方法
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
RU2525512C1 (ru) * 2013-03-28 2014-08-20 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ медикаментозного расширения ригидного зрачка перед проведением факоэмульсификации
KR20160070077A (ko) * 2013-10-03 2016-06-17 임프리미스 파마슈티컬스 인코포레이티드 안구내 투여를 위한 에피네프린-기반 안과용 조성물 및 이의 제조 방법
CN105213418B (zh) * 2015-11-11 2019-01-22 中国人民解放军第四军医大学 一种眼科术前用复方滴眼液及其制备方法
JP2019524896A (ja) 2016-08-25 2019-09-05 ハーロウ・ヘルス・インコーポレイテッドHarrow Health, Inc. 眼内投与のためのエピネフリンベースの眼科組成物及びその製造方法
RU2649534C1 (ru) * 2017-05-10 2018-04-03 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ анестезии при факоэмульсификации катаракты
RU2662423C1 (ru) * 2017-07-26 2018-07-25 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ проведения обезболивания при выполнении витреоретинальных операций

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026323A (en) * 1960-03-22 1962-03-20 Rubin J Schacter Salts of tribasic acids
JPH0780760B2 (ja) * 1986-07-28 1995-08-30 ライオン株式会社 安定化されたフエニレフリン系液剤
JP3066561B2 (ja) * 1993-10-07 2000-07-17 武田薬品工業株式会社 近視予防・治療剤
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
US5779661A (en) * 1995-12-11 1998-07-14 Physion, S.R.L. Method of treating dysfunctional bladder syndromes by electromotive drug administration
US6319240B1 (en) * 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
WO2001034088A2 (en) * 1999-11-12 2001-05-17 Leo Rubin Cardiac device for electrical and chemical regulation, and vasoactive intestinal peptide for treatment of cardiopulmonary disorders
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
JP4150846B2 (ja) * 2001-03-28 2008-09-17 参天製薬株式会社 ステロイドを有効成分とする網脈絡膜疾患治療剤
US20040013729A1 (en) * 2002-07-18 2004-01-22 Buono Lawrence M. Single-drop multiple-agent composition for topical delivery to the eye
CA2866848C (en) * 2002-07-30 2017-01-03 Omeros Corporation Ophthalmologic irrigation solutions and method

Also Published As

Publication number Publication date
LT1858481T (lt) 2019-07-10
FR2882930B1 (fr) 2009-03-27
LUC00136I1 (lt) 2019-11-04
NO20074850L (no) 2007-09-24
US20080194649A1 (en) 2008-08-14
NO339793B1 (no) 2017-01-30
NL301017I2 (nl) 2020-04-30
IL185197A0 (en) 2008-01-06
SI1858481T1 (sl) 2019-08-30
NO2017008I1 (no) 2017-03-24
DK1858481T3 (da) 2019-06-03
BRPI0607416A2 (pt) 2009-09-08
TR201908487T4 (tr) 2019-07-22
NL301017I1 (nl) 2019-11-06
MX2007010295A (es) 2007-12-11
CY2019042I2 (el) 2020-05-29
ES2728071T3 (es) 2019-10-22
EP1858481B1 (fr) 2019-05-08
RU2392925C2 (ru) 2010-06-27
RU2007137115A (ru) 2009-04-20
CY1121865T1 (el) 2020-05-29
CY2019042I1 (el) 2020-05-29
HRP20191044T1 (hr) 2019-09-06
PT1858481T (pt) 2019-06-14
EP1858481A1 (fr) 2007-11-28
KR20070111501A (ko) 2007-11-21
MA29269B1 (fr) 2008-02-01
CA2598503C (fr) 2014-01-28
US20120220637A1 (en) 2012-08-30
WO2006095095A1 (fr) 2006-09-14
LUC00136I2 (lt) 2021-02-12
CA2598503A1 (fr) 2006-09-14
NO2017008I2 (no) 2017-03-24
FR2882930A1 (fr) 2006-09-15
HUE043668T2 (hu) 2019-08-28
PL1858481T3 (pl) 2019-09-30
US9289399B2 (en) 2016-03-22
JP2008532985A (ja) 2008-08-21
TNSN07343A1 (fr) 2008-12-31
CN101151018A (zh) 2008-03-26

Similar Documents

Publication Publication Date Title
LTPA2019017I1 (lt) Oftalmologinės kompozicijos ir jų panaudojimas
LTPA2017002I1 (lt) Aerozoliniai fluorchinolinai ir jų naudojimas
ITMI20050728A1 (it) Formulazione innovativa
DK1965646T3 (da) Herbicid sammensætning
DK1811959T4 (da) Oftalmiske sammensætninger
DK1988877T3 (da) Terapeutiske sammensætninger omfattende ingenol-3-angelat
DE502006006338D1 (de) Ächen
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
RU2398586C3 (ru) Фармацевтическая композиция
NO20055686D0 (no) Sammensetning
ATE535505T1 (de) Landwirtschaftliche zusammensetzung
DE602006012066D1 (de) Daraus
DE602006016137D1 (de) Harzzusammensetzungen und harzformkörper
DK1741339T3 (da) Pesticid sammensætning
DE502006006590D1 (de) Biozide zusammensetzungen
ATE510595T1 (de) Haarbehandlungszusammensetzungen
ATE504334T1 (de) Haarbehandlungszusammensetzungen
DE602006014275D1 (de) Copolymer und reinigungsmittelzusammensetzungen damit
DE602006018485D1 (de) Herbizide zusammensetzung
DE502006001206D1 (de) Objektiv und Mikroskop
DE602006011271D1 (de) Anthelminthische zusammensetzung
DE502006004891D1 (de) Agrochemische zusammensetzung
ATE410060T1 (de) Herbizide zusammensetzungen auf basis von 3- phenyluracilen und 3-sulfonylisoxazolinen
ITMI20051658A1 (it) Composizioni cosmetiche
DE602006001128D1 (de) Alkylcycloheptylmethylcarbonate und Riechstoffkompositionen